121 related articles for article (PubMed ID: 14981982)
1. Angiogenic switch in earliest stages of human colonic tumorigenesis.
Shpitz B; Gochberg S; Neufeld D; Grankin M; Buklan G; Klein E; Bernheim J
Anticancer Res; 2003; 23(6D):5153-7. PubMed ID: 14981982
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin expression is altered in human colonic aberrant crypt foci.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
[TBL] [Abstract][Full Text] [Related]
3. Oncoprotein coexpression in human aberrant crypt foci and minute polypoid lesions of the large bowel.
Shpitz B; Bomstein Y; Shalev M; Liverant S; Kaufman Z; Klein E; Mekori Y; Bernheim J
Anticancer Res; 1999; 19(4B):3361-6. PubMed ID: 10652634
[TBL] [Abstract][Full Text] [Related]
4. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
[TBL] [Abstract][Full Text] [Related]
5. Histomorphology of aberrant crypt foci in colorectal carcinoma.
Norlida AO; Phang KS
Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
[TBL] [Abstract][Full Text] [Related]
6. The association between tumour progression and vascularity in the oral mucosa.
Pazouki S; Chisholm DM; Adi MM; Carmichael G; Farquharson M; Ogden GR; Schor SL; Schor AM
J Pathol; 1997 Sep; 183(1):39-43. PubMed ID: 9370945
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci.
Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
[TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt foci in human colon carcinogenesis.
Dolara P; Caderni G; Lancioni L; Giannini A; Anastasi A; Fazi M; Castiglione G
Cancer Detect Prev; 1997; 21(2):135-40. PubMed ID: 9101074
[TBL] [Abstract][Full Text] [Related]
9. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
Seike K; Koda K; Oda K; Kosugi C; Shimizu K; Nishimura M; Shioiri M; Takano S; Ishikura H; Miyazaki M
Am J Gastroenterol; 2006 Jun; 101(6):1362-9. PubMed ID: 16771962
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
11. Classification of aberrant crypt foci and microadenomas in human colon.
Roncucci L; Medline A; Bruce WR
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
[TBL] [Abstract][Full Text] [Related]
12. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
13. Aberrant crypt foci in colon cancer epidemiology.
Khare S; Chaudhary K; Bissonnette M; Carroll R
Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
15. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
16. Aberrant crypt focus size predicts distal polyp histopathology.
Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
[TBL] [Abstract][Full Text] [Related]
17. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer.
Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
[TBL] [Abstract][Full Text] [Related]
19. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
